0001213900-23-095419.txt : 20231213
0001213900-23-095419.hdr.sgml : 20231213
20231213164355
ACCESSION NUMBER: 0001213900-23-095419
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231211
FILED AS OF DATE: 20231213
DATE AS OF CHANGE: 20231213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bassan Merav
CENTRAL INDEX KEY: 0001792702
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38762
FILM NUMBER: 231484543
MAIL ADDRESS:
STREET 1: C/O BIOMX LTD.
STREET 2: 7 PINHAS SAPIR ST., FLOOR 2
CITY: NESS ZIONA
STATE: L3
ZIP: 7414002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BiomX Inc.
CENTRAL INDEX KEY: 0001739174
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 EINSTEIN ST., 4TH FLOOR
CITY: NESS ZIONA
STATE: L3
ZIP: 7414003
BUSINESS PHONE: (972) 72 394 2377
MAIL ADDRESS:
STREET 1: 22 EINSTEIN ST., 4TH FLOOR
CITY: NESS ZIONA
STATE: L3
ZIP: 7414003
FORMER COMPANY:
FORMER CONFORMED NAME: Chardan Healthcare Acquisition Corp.
DATE OF NAME CHANGE: 20180430
4
1
ownership.xml
X0508
4
2023-12-11
0
0001739174
BiomX Inc.
PHGE
0001792702
Bassan Merav
C/O BIOMX INC.,
22 EINSTEIN ST., FLOOR 4
NESS ZIONA,
L3
7414003
ISRAEL
0
1
0
0
Chief Development Officer
0
Common Stock Options - Right to Buy
7.02
2023-12-11
4
D
0
47500
D
2031-03-30
Common Stock
47500
0
D
Common Stock Options - Right to Buy
0.2749
2023-12-11
4
A
0
12500
A
2031-03-30
Common Stock
12500
12500
D
Common Stock Options - Right to Buy
1.41
2023-12-11
4
D
0
100000
D
2032-03-29
Common Stock
100000
0
D
Common Stock Options - Right to Buy
0.2749
2023-12-11
4
A
0
71429
A
2032-03-29
Common Stock
71429
71429
D
On December 11, 2023, the Issuer canceled, pursuant to the Issuer's option exchange program, an option for 47,500 shares of the Issuer's common stock granted to the Reporting Person on March 30, 2021. In exchange, the Reporting Person received a replacement option, for 12,500 shares, having an exercise price of $0.2749 per share.
The cancelled option provided for vesting over four years, with 25% of the shares subject to the option vested on March 30, 2022, and the remainder vested in 12 equal quarterly installments over three years. The replacement option vests according to the same vesting schedule applicable to the cancelled option; provided, however, that the replacement option may not be exercised prior to December 11, 2024.
On December 11, 2023, the Issuer canceled, pursuant to the Issuer's option exchange program, an option for 100,000 shares of the Issuer's common stock granted to the Reporting Person on March 29, 2022. In exchange, the Reporting Person received a replacement option, for 71,429 shares, having an exercise price of $0.2749 per share.
The cancelled option provided for vesting over four years, with 25% of the shares subject to the option vested on March 29, 2023, and the remainder vested in 12 equal quarterly installments over three years. The replacement option vests according to the same vesting schedule applicable to the cancelled option; provided, however, that the replacement option may not be exercised prior to December 11, 2024.
/s/ Merav Bassan
2023-12-13